If you don’t know all the risks that come along with using drugs off label with your residents who suffer from dementia or Alzheimer’s, you’re putting them at risk for stroke, seizures, or worse. While this practice can be effective, a growing body of research raises serious questions about the safety and efficacy of these drugs among the elderly. Let long term care expert Christie Teigland lay out all the pros and cons so you can best serve your patients while also protecting yourself.
Have additional questions? You have the floor with the speaker during an interactive Q&A.
Who should attend? Nurses; nurse practitioners; medical directors and physicians; nursing home interdisciplinary staff including psychologists, social workers, directors of nursing, quality improvement and risk management staff; pharmacists, and other clinicians involved in long term care and care of geriatric patients with dementia/Alzheimer Disease.
Your registration includes:
- Carmen Bowman
Dr. Christie Teigland has specialized in long term care quality measurement research for the past 10 years. She has served as Principal Investigator for six large outcome studies, including a 4-year patient safety project funded by DHHS (AHRQ) that developed innovative predictive risk reports for falls and pressure ulcers.
In 2005, DHHS (HRSA) awarded Dr. Teigland a large nurse education grant to develop online education modules to provide... More Info
More Events By The Speaker